Effect of a single dose of insulin glargine/lixisenatide fixed ratio combination (iGlarLixi) on postprandial glucodynamic response in Japanese patients with type 2 diabetes mellitus: A phase I randomized trial

This report describes novel clinical data assessing the pharmacodynamics of insulin glargine/lixisenatide (iGlarLixi) compared with placebo and insulin glargine alone, to determine pharmacokinetics of lixisenatide, and to assess safety of iGlarLixi in Japanese people with type 2 diabetes mellitus (T...

Descripción completa

Detalles Bibliográficos
Autores principales: Inoue, Megumi, Lorenz, Martin, Muto, Hideya, Wesch, Roland, Hashimoto, Yasuhiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2019
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771557/
https://www.ncbi.nlm.nih.gov/pubmed/31050109
http://dx.doi.org/10.1111/dom.13757

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6771557/
https://www.ncbi.nlm.nih.gov/pubmed/31050109
http://dx.doi.org/10.1111/dom.13757

Ejemplares similares